Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A randomized trial evaluating low-dose intracoronary adjunctive tenecteplase during primary PCI [percutaneous coronary intervention] for ST-elevation myocardial infarction (ICE-T).

Trial Profile

A randomized trial evaluating low-dose intracoronary adjunctive tenecteplase during primary PCI [percutaneous coronary intervention] for ST-elevation myocardial infarction (ICE-T).

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 02 Jan 2020

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Tenecteplase (Primary)
  • Indications Embolism and thrombosis; Myocardial infarction
  • Focus Therapeutic Use
  • Acronyms ICE-T; ICE-T-TIMI49
  • Most Recent Events

    • 20 Nov 2019 Primary endpoint (Percent Diameter Stenosis of the Culprit Lesion Following the First Bolus of Study Drug Prior to Primary Percutaneous Coronary Intervention) has not been met as per results published in the American Journal of Cardiology
    • 20 Nov 2019 Results published in the American Journal of Cardiology
    • 01 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top